Landos Biopharma, Inc.
LABP · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9 | -$6 | -$6 | -$4 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $2 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $1 | $3 | -$1 |
| Other Non-Cash | $0 | -$2 | -$0 | $0 |
| Operating Cash Flow | -$8 | -$5 | -$2 | -$5 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $1 | $4 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $1 | $4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$17 | $0 | -$0 |
| Stock Repurch. | $0 | $20 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$5 | $0 | -$0 |
| Financing Cash Flow | $0 | -$2 | $0 | -$0 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$8 | -$5 | -$2 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $38 | $42 | $44 | $45 |
| End Cash | $29 | $38 | $42 | $44 |
| Free Cash Flow | -$8 | -$5 | -$2 | -$5 |